Practice
An emerging multidrug-resistant bacteria
Jennie Johnstone and Samir N. Patel; on behalf of the Provincial Infectious Diseases Advisory Committee – Infection Prevention and Control (PIDAC-IPC)
CMAJ September 05, 2017 189 (35) E1115; DOI: https://doi.org/10.1503/cmaj.170110
Jennie Johnstone
Public Health Ontario (Johnstone, Patel); Dalla Lana School of Public Health (Johnstone), University of Toronto; Department of Laboratory Medicine and Pathobiology (Patel), University of Toronto, Toronto, Ont.
MD PhDSamir N. Patel
Public Health Ontario (Johnstone, Patel); Dalla Lana School of Public Health (Johnstone), University of Toronto; Department of Laboratory Medicine and Pathobiology (Patel), University of Toronto, Toronto, Ont.
PhDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
An emerging multidrug-resistant bacteria
Jennie Johnstone, Samir N. Patel
CMAJ Sep 2017, 189 (35) E1115; DOI: 10.1503/cmaj.170110
Jump to section
- Article
- Carbapenemase-producing Enterobacteriaceae (CPE) are emerging multidrug-resistant bacteria
- CPE is most commonly acquired in hospitals and long-term care facilities
- CPE infection has similar clinical manifestations to those of other gram-negative bacteria
- There are limited treatment options for CPE
- Preventing the spread of CPE requires multiple measures
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Podcast